Cell Proliferation and Cell Loss in Progression in Liver Carcinogenesis: A New Hypothesis
It is becoming well established that the development of hepatocellular carcinoma in the liver of the rat occurs through a number of steps (8 to 10 or more), some of which involve changes in a rare cell and others the progressive modulation of the phenotype in new hepatocyte populations1. Two major sequences appear in the majority of the models of liver carcinogenesis1,2. Sequence A, consisting of initiation and promotion, generates benign focal proliferations of hepatocytes (“clonal nodules”), a very small proportion (1–5%) of which persist2. Sequence B, consisting of progression, is the multistep process whereby the first precancerous lesion, the persistent hepatocyte nodule, slowly undergoes a series of changes leading to cancer. This sequence also includes the changes that occur in a bona fide cancer leading to increasing growth, invasion and metastasis2. Clearly, sequence B is the most relevant and most critical in the development of cancer. It can occur “spontaneously” and needs no external manipulation and is often not influenced in a major way by promoting environments.
KeywordsCell Loss Precancerous Lesion Cyproterone Acetate Orotic Acid Liver Carcinogenesis
E. Farber and D. S. R. Sarma, Biology of Disease: Hepatocarcinogenesis: a dynamic cellular perspective, Lab. Invest.
56:4 (1987).PubMedGoogle Scholar
E. Farber, Some emerging general principles in the pathogenesis of hepatocellular carcinoma, Cancer Surveys
5:695 (1986).PubMedGoogle Scholar
E. Farber, Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes Memorial Lecture, Cancer Res.
44:5463 (1984).PubMedGoogle Scholar
J. Rotstein, P. D. M. Macdonald, H. M. Rabes and E. Farber, Cell cycle kinetics of rat hepatocytes in early putative preneoplastic lesions in hepatocarcinogenesis, Cancer Res.
44:2913 (1984).PubMedGoogle Scholar
J. Rotstein, D. S. R. Sarma and E. Farber, Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis, Cancer Res.
46:2377 (1986).PubMedGoogle Scholar
M. Tatematsu, G. Lee, M. A. Hayes and E. Farber, Progression of hepatocarcinogenesis: differences in growth and behaviour of transplants of early and late hepatocyte nodules in the spleen, Cancer Res.
47:4699 (1987).PubMedGoogle Scholar
K. Enomoto and E. Farber, Kinetics of phenotypic maturation of remodeling of hyperplastic nodules during liver carcinogenesis, Cancer Res.
42:2330 (1982).PubMedGoogle Scholar
M. Tatematsu, Y. Nagamine and E. Farber, Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normalappearing liver, Cancer Res.
43:5049 (1983).PubMedGoogle Scholar
R. Schulte-Hermann, Adaptive liver growth induced by xenobiotic compounds and other stimuli, Crit. Rev. Toxicol.
3:97 (1974).CrossRefGoogle Scholar
R. Schulte-Hermann, Reactions of the liver to injury: adaptation, in
: “Toxic Injury of the Liver”, E. Farber and M. M. Fisher, eds., Marcel Dekker, New York (1979).Google Scholar
N. Bohm and B. Moser, Reversible hyperplasia and hypertrophy of the mouse liver induced by a functional charge with phenobarbital, Beitr. Pathol.
157:283 (1976).PubMedCrossRefGoogle Scholar
W. G. Levine, M. G. Ord and L. A. Stocken, Some biochemical changes associated with nafenopin-induced liver growth in the rat, Biochem. Pharmacol.
26:939 (1977).PubMedCrossRefGoogle Scholar
R. Schulte-Hermann, V. Hoffman, W. Parzefall, M. Kallenbach, A. Gerhard and J. Schuppler, Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers, II, Induction of growth, Chem. Biol. Interact.
31:287 (1980).PubMedCrossRefGoogle Scholar
A. Columbano, G. M. Ledda, P. Sirigu, T. Perra and P. Pani, Liver cell proliferation induced by a single dose of lead nitrate, Am. J. Pathol.
110:83 (1983).PubMedGoogle Scholar
W. Bursch, B. Lauer, I. Timmermann-Trosiener, G. Barthel, J. Schuppler and R. Schulte-Hermann, Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters, Carcinogenesis
5:453 (1984).PubMedCrossRefGoogle Scholar
A. Columbano, G. M. Ledda-Columbano, P. P. Coni, G. Faa, C. Liguori, G. Santa Cruz and P. Pani, Occurrence of cell death (apoptosis) during the involution of liver hyperplasia, Lab. Invest.
52:670 (1985).PubMedGoogle Scholar
A. Columbano, G. M. Ledda-Columbano, P. M. Rao, S. Rajalakshmi and D. S. R. Sarma, Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells, Am. J. Pathol.
116:441 (1984).PubMedGoogle Scholar
D. Solt and E. Farber, New principle for the analysis of chemical carcinogenesis, Nature (Lond)
268:702 (1976).Google Scholar
H. Tsuda, G. Lee and E. Farber, Induction of resistant hepatocytes as a new principle for the possible short-term in vivo test for carcinogens, Cancer Res.
40:1157 (1980).PubMedGoogle Scholar
E. Farber, Resistance phenotype in the initiation and promotion of chemical hepatocarcinogenesis, Chemica Scripta
27A:131 (1987).Google Scholar
D. B. Solt, A. Medline, and E. Farber, Rapid emergence of carcinogeninduced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis, Am. J. Pathol.
88:595 (1977).PubMedGoogle Scholar
A. Columbano, G. M. Ledda-Columbano, G. Lee, S. Rajalakshmi, and D. S. R. Sarma, Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens Cancer Res.
47:5557 (1987).PubMedGoogle Scholar
R. Schulte-Hermann, I. Timmermann-Trosiener, and J. Schuppler, Response of liver foci in rats to hepatic tumor promoters, Toxicol. Pathol.
10:63 (1982).CrossRefGoogle Scholar
H. Popper, S. S. Sternberg, B. C. Oser, and M. Oser, The carcinogenic effect of aramite in rats. A study of hepatic nodules, Cancer(Phila)
13:1035 (1960).CrossRefGoogle Scholar
© Springer Science+Business Media New York 1988